CoChat

Extracellular nicotinamide phosphoribosyltransferase, a new cancer metabokine

Open access
Grolla, Ambra A, Travelli, Cristina, Genazzani, Armando A, Sethi, Jaswinder K · 2016 · British Journal of Pharmacology
Cited by 115

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Abstract

In this review, we focus on the secreted form of nicotinamide phosphoribosyltransferase (NAMPT); extracellular NAMPT (eNAMPT), also known as pre‐B cell colony‐enhancing factor or visfatin. Although intracellular NAMPT is a key enzyme in controlling NAD metabolism, eNAMPT has been reported to function as a cytokine, with many roles in physiology and pathology. Circulating eNAMPT has been associated with several metabolic and inflammatory disorders, including cancer. Because cytokines produced in the tumour micro‐environment play an important role in cancer pathogenesis, in part by reprogramming cellular metabolism, future improvements in cancer immunotherapy will require a better understanding of the crosstalk between cytokine action and tumour biology. In this review, the knowledge of eNAMPT in cancer will be discussed, focusing on its immunometabolic function as a metabokine, its secretion, its mechanism of action and possible roles in the cancer micro‐environment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/bph.13505

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

2 retracted

Show all 14 references

Cited by

See all 115

Metadata

Authors
Grolla, A. A., Travelli, C., Genazzani, A. A., & Sethi, J. K.
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
2016-06-02
Volume
173
Issue
14
Pages
2182-2194
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W2343462384
Cited by
115
References
14
FWCI
4.87
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Extracellular nicotinamide phosphoribosyltransferase, a new cancer metabokine. https://app.cochat.ai/papers/10.1111/bph.13505
The paper
Grolla, A. A., Travelli, C., Genazzani, A. A., & Sethi, J. K. (2016). Extracellular nicotinamide phosphoribosyltransferase, a new cancer metabokine. British Journal of Pharmacology. https://doi.org/10.1111/bph.13505

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.